Saudi FDA: Working with Industry to Improve the Reporting of Adverse Reactions

Summary: In this interview Dr. Nasser Al-Qahtani, Head, Adverse Drug Reactions Evaluation Department Saudi FDA speaks to Andrea Charles from Pharma IQ, about the Saudi FDA pharmacovigilance system and what new guidelines he predicts will be areas for discussion amongst pharma/bio